![[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)](https://image.mono.ipros.com/public/product/image/e24/2000951247/IPROS82448291468176721375.jpeg?w=280&h=280)
[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)
The global market for preimplantation genetic diagnosis (PGD) is expected to reach new heights by 2031, with an estimated value of 198,603.5 thousand US dollars.
The global preimplantation genetic diagnosis (PGD) market has achieved remarkable growth, providing hope and advanced solutions for individuals and couples aiming to expand their families. The sales revenue in 2022 was approximately $81,520.2 thousand, but it is estimated to soar to $198,603.5 thousand by 2031, with a steady compound annual growth rate (CAGR) of 10.4% projected during the forecast period from 2023 to 2031. The global PGD market is at the forefront of technological innovation in reproductive medicine. With advancements in medicine, the ability to conduct genetic testing on preimplantation embryos has significantly changed family planning. PGD enables individuals and couples to make informed decisions by identifying genetic abnormalities, hereditary diseases, and chromosomal abnormalities that could affect the health of future children. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.
- 企業：Panorama Data Insights Ltd.
- 価格：Other
